Journal of Clinical Endocrinology & Metabolism, Vol 45, 299-306, Copyright © 1977 by Endocrine Society

ARTICLES

The importance of phosphate in regulating plasma 1,25-(OH)2-vitamin D levels in humans: studies in healthy subjects in calcium-stone formers and in patients with primary hyperparathyroidism

RW Gray, DR Wilz, AE Caldas and J Lemann Jr

We observed that plasma 1,25-(OH)2-D concentrations average 87 +/- 30 SD pmol/l in 48 healthy adults without a personal or family history of kidney stones. Plasma 1,25-(OH)2-D concentrations were significantly elevated among 26 patients with recurrent calcium-containing renal stones and hypophosphatemia: 150 +/- 74 pmol/l; P less than 0.001, and among 9 patients with proven parathyroid adenoma and hypophosphatemia: 200 +/- 54 pmol/l; P less than 0.001. Plasma 1,25-(OH)2-D levels in these 3 groups were inversely correlated with serum phosphate concentration: plasma 1,25-(OH)2-D, pmol/l = 282 - 141 X serum PO4, mmol/l; r = 0.51; P less than 0.001. During dietary PO4 deprivation lasting 11 to 16 days in 10 healthy women, serum PO4 fell and plasma 1,25-(OH)2-D concentrations rose whereas in 8 healthy men neither serum PO4 nor 1,25-(OH)2-D concentrations changed. The change from control in plasma 1,25-(OH)2-D levels were correlated with the change from control in serum PO4 concentrations: delta1,25-(OH)2-D, pmol/l = 1 - 82 X delta serum PO4 mmol/l; r = 0.59; P less than 0.01. We conclude that reductions in serum PO4 concentrations, either directly or indirectly, stimulate renal synthesis of 1,25-(OH)2-D in humans.

This article has been cited by other articles:

				F. Perwad, N. Azam, M. Y. H. Zhang, T. Yamashita, H. S. Tenenhouse, and A. A. Portale Dietary and Serum Phosphorus Regulate Fibroblast Growth Factor 23 Expression and 1,25-Dihydroxyvitamin D Metabolism in Mice Endocrinology, December 1, 2005; 146(12): 5358 - 5364. [Abstract] [Full Text] [PDF]

				M. J. Favus, A. J. Karnauskas, J. H. Parks, and F. L. Coe Peripheral Blood Monocyte Vitamin D Receptor Levels Are Elevated in Patients with Idiopathic Hypercalciuria J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4937 - 4943. [Abstract] [Full Text] [PDF]

				N. Azam, M. Y. H. Zhang, X. Wang, H. S. Tenenhouse, and A. A. Portale Disordered Regulation of Renal 25-Hydroxyvitamin D-1{alpha}-Hydroxylase Gene Expression by Phosphorus in X-Linked Hypophosphatemic (Hyp) Mice Endocrinology, August 1, 2003; 144(8): 3463 - 3468. [Abstract] [Full Text] [PDF]

				D. Prie, V. Huart, N. Bakouh, G. Planelles, O. Dellis, B. Gerard, P. Hulin, F. Benque-Blanchet, C. Silve, B. Grandchamp, et al. Nephrolithiasis and Osteoporosis Associated with Hypophosphatemia Caused by Mutations in the Type 2a Sodium-Phosphate Cotransporter N. Engl. J. Med., September 26, 2002; 347(13): 983 - 991. [Abstract] [Full Text] [PDF]

				M. Y. H. Zhang, X. Wang, J. T. Wang, N. A. Compagnone, S. H. Mellon, J. L. Olson, H. S. Tenenhouse, W. L. Miller, and A. A. Portale Dietary Phosphorus Transcriptionally Regulates 25-Hydroxyvitamin D-1{alpha}-Hydroxylase Gene Expression in the Proximal Renal Tubule Endocrinology, February 1, 2002; 143(2): 587 - 595. [Abstract] [Full Text] [PDF]